Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 2Tumor-Agnostic 1Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 96Carcinoma, Ovarian Epithelial 31Fallopian Tube Neoplasms 28Breast Neoplasms 25Carcinoma, Non-Small-Cell Lung 21Melanoma 20Uterine Cervical Neoplasms 16Pancreatic Neoplasms 14Neoplasm Metastasis 13Colorectal Neoplasms 13Stomach Neoplasms 11Triple Negative Breast Neoplasms 10Carcinoma, Hepatocellular 10Sarcoma 9Lung Neoplasms 9Head and Neck Neoplasms 9Recurrence 8Neoplasms 8Anus Neoplasms 8Multiple Myeloma 7Esophageal Neoplasms 7Sarcoma, Synovial 6Neuroblastoma 6Carcinoma, Renal Cell 6Vaginal Neoplasms 5Urinary Bladder Neoplasms 5Testicular Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Penile Neoplasms 5Lymphoma, Non-Hodgkin 5

Interventions

pembrolizumab 5Cisplatin 4Paclitaxel 3lenvatinib 2Fluorouracil 2trastuzumab deruxtecan 1sargramostim 1resiquimod 1poly ICLC 1oregovomab 1liposomal doxorubicin 1fluoroazomycin arabinoside 1fludarabine 1cemiplimab 1catumaxomab 1cabozantinib 1Therapeutics 1Therapeutic Irrigation 1TKM-080301 1Radiation, Ionizing 1Radiation 1Quality of Life 1Proctoscopy 1Prednisone 1Prednisolone 1Patient Reported Outcome Measures 1Papanicolaou Test 1Oxaliplatin 1Nelfinavir 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Cyclophosphamide × Gynecologic × Clear all
NCT05922930 2026-05-06

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
51 enrolled
GastrointestinalGynecologic

Adenocarcinoma, Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡